← Back to Search

Diagnostic Test

Self-Collected Screening Workshops for Cervical Cancer

N/A
Waitlist Available
Led By Jessica Dalby, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Fluent understanding in Karenni
Fluent understanding in Hmong
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 day (pre workshop and post-workshop, up to 3 hours between surveys)
Awards & highlights

Study Summary

This trial will compare whether educational workshops on HPV and self-collected screenings will increase participation in cervical cancer screenings among Hmong and Karenni refugee and immigrant populations in Wisconsin compared to just offering clinician collected screenings.

Who is the study for?
This trial is for Southeast Asian immigrant and refugee women in Wisconsin who understand Karenni, English, or Hmong. It's not for those who are pregnant, have had a hysterectomy, or can't make decisions well.Check my eligibility
What is being tested?
The study tests if educational workshops with self-collected HPV swabs increase cervical cancer screening compared to clinician-collected swabs. Participants will be divided into groups to compare the different methods.See study design
What are the potential side effects?
There may be minimal side effects related to collecting the cervical swab such as discomfort or slight bleeding. The workshop itself has no physical side effects but could include time commitment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You can speak and understand Karenni language fluently.
Select...
You can speak and understand Hmong language fluently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 day (pre workshop and post-workshop, up to 3 hours between surveys)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 day (pre workshop and post-workshop, up to 3 hours between surveys) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants Who Obtain or Self-Report Future Desire for Cervical Cancer Screening
Secondary outcome measures
Number of Participants willing to use HPV self-collect device for their cervical cancer screening
Participant Satisfaction With Educational Workshops Survey Scores

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment2 Interventions
Participants take a workshop where they are provided all the same education as control as well as additional education on self-collection for HPV-only testing using vaginal swab as an additional method.
Group II: ControlActive Control1 Intervention
Participants take a workshop where they are provided education on standard-of-care for cervical cancer screening such as pap smear and HPV testing through clinician-collection methods using speculum and cervical swabs.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Workshop plus Participant-Collected Cervical Swab
2022
N/A
~150
HPV testing on Participant-Collected Cervical Swab Samples
2022
N/A
~150

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,176 Previous Clinical Trials
3,011,857 Total Patients Enrolled
Milwaukee Consortium for Hmong Health (MCHH)UNKNOWN
Jessica Dalby, MDPrincipal InvestigatorUW School of Medicine and Public Health

Media Library

HPV testing on Participant-Collected Cervical Swab Samples (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT05286749 — N/A
Cervical Cancer Screening Research Study Groups: Control, Intervention
Cervical Cancer Screening Clinical Trial 2023: HPV testing on Participant-Collected Cervical Swab Samples Highlights & Side Effects. Trial Name: NCT05286749 — N/A
HPV testing on Participant-Collected Cervical Swab Samples (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05286749 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are they still accepting new participants into this research study?

"Clinicaltrials.gov states that this trial, which was first posted on August 13th 2022 and last modified on the 31st of same month, is no longer seeking patients. However, there are 318 other clinical trials in search for individuals at present time."

Answered by AI

What qualifications make one an optimal candidate for this medical experiment?

"This medical trial seeks 250 participants who possess the eef1a1 protein, human and are between 25 to 65 years of age. Additionally, all potential patients must have a working understanding of English, Hmong or Karenni."

Answered by AI

Does this research experiment accommodate those under the age of 30?

"This clinical trial is exclusively open to adults aged 25-65. Meanwhile, there are 10 trials for younger individuals and 284 studies that focus on those over 65 years old."

Answered by AI
~58 spots leftby Mar 2025